MON-114 Effect of Selective Mineralocorticoid Receptor Antagonist on liver Fat and Metabolism in Patients with Type 2 Diabetes: A Randomized Controlled Trail

OBJECTIVE Non-alcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes. A growing body of evidence points at a beneficial effect of MR antagonists (MRAs) on adipocyte function via the inhibition of adipocyte differentiation, downregulation of rho-kinase activity, pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kistorp, Caroline, Johansen, Marie Louise, Rossignol, Patrick, Refsgaard Holm, Maria, Rasmussen, Jon, Chabanova, Elizaveta, Dela, Flemming, faber, jens, Schou, Morten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Adipose Tissue, Appetite, and Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551099/
http://dx.doi.org/10.1210/js.2019-MON-114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551099/
http://dx.doi.org/10.1210/js.2019-MON-114

Ejemplares similares